Why prescribe ICS to Dutch COPD patients in primary care, and when and how to stop. Data from focus groups with patients and health care providers

C. De Jong (Groningen, Netherlands), J. Van Boven (Groningen, Netherlands), T. Schermer (Nijmegen, Netherlands), R. Riemersma (Groningen, Netherlands), E. Brill (Groningen, Netherlands), M. Van Den Berge (Groningen, Netherlands), T. Van Der Molen (Groningen, Netherlands), J. Kocks (Groningen, Netherlands)

Source: International Congress 2018 – Primary care management of COPD
Session: Primary care management of COPD
Session type: Thematic Poster
Number: 917
Disease area: Airway diseases

Congress or journal article abstractE-poster

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
C. De Jong (Groningen, Netherlands), J. Van Boven (Groningen, Netherlands), T. Schermer (Nijmegen, Netherlands), R. Riemersma (Groningen, Netherlands), E. Brill (Groningen, Netherlands), M. Van Den Berge (Groningen, Netherlands), T. Van Der Molen (Groningen, Netherlands), J. Kocks (Groningen, Netherlands). Why prescribe ICS to Dutch COPD patients in primary care, and when and how to stop. Data from focus groups with patients and health care providers. 917

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you: